Phosphodiesterase 10 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/04 (2006.01) A61K 31/502 (2006.01) A61K 31/517 (2006.01) A61P 25/18 (2006.01) C07D 401/14 (2006.01) C07D 413/04 (2006.01)

Patent

CA 2644280

The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

La présente invention concerne certains composés de cinnoline qui sont des inhibiteurs de la PDE10, des compositions pharmaceutiques contenant ces composés et des procédés de préparation de ces composés. L'invention concerne également des procédés de traitement de maladies médiées par l'enzyme PDE10 telles que l'obésité, le diabète non insulinodépendant, la schizophrénie, le trouble bipolaire, le trouble obsessionnel compulsif et similaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Phosphodiesterase 10 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphodiesterase 10 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphodiesterase 10 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1593099

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.